Synergistic Positive Feedback Mechanisms Underlying Seizure Initiation
Andrew J Trevelyan1, Robert T Graham2, R Ryley Parrish3
1Newcastle University Biosciences Institute, Medical School, Framlington Place, Newcastle upon Tyne, United Kingdom.
Epilepsy Currents
|March 16, 2023
Summary
Dendritic plateau potentials, crucial for brain excitability, may play a key role in initiating seizures (ictogenesis). This study highlights their importance in understanding epilepsy progression.
Area of Science:
- Neuroscience
- Epilepsy research
- Cellular excitability
Background:
- Current epilepsy research primarily focuses on interneurons, chloride homeostasis, and potassium levels.
- The role of dendritic plateau potentials in seizure initiation has been historically overlooked despite significant evidence.
- A 40-year body of literature suggests the general importance of dendritic plateau potentials in epilepsy.
Purpose of the Study:
- To investigate the role of dendritic plateau potentials in the ictogenic transition.
- To re-evaluate the significance of dendritic excitability in seizure initiation.
- To propose a coordinated increase in pyramidal cell dendritic excitability as a key stage in ictogenesis.
Main Methods:
- Review of existing literature on dendritic plateau potentials and epilepsy.
- Analysis of cellular mechanisms underlying ictogenesis.
- Theoretical modeling of neuronal network behavior during seizure onset.
Main Results:
- Evidence suggests dendritic plateau potentials are critical for neuronal excitability.
- A coordinated increase in dendritic excitability across pyramidal cells is proposed as a central mechanism.
- This mechanism offers a new perspective on the transition from normal brain activity to seizures.
Conclusions:
- Dendritic plateau potentials represent a significant, yet understudied, factor in seizure initiation.
- Increased dendritic excitability in pyramidal neurons is a key event in ictogenesis.
- Future research should explore therapeutic strategies targeting dendritic excitability to prevent seizures.
Related Concept Videos
Epilepsy and Seizures: Overview
235
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
235
Integration of Synaptic Events
1.6K
Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...
1.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators
487
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
487
Seizures: Classification
492
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
492
Overview of Synapses
2.4K
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
2.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
381
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
381


